Trump Tells FDA to Look Into Malaria Drug

Trump Tells FDA to Look Into Malaria Drug

On Tuesday, a team of French scientists released the first results of a clinical study of the use of hydroxychloroquine on 24 coronavirus patients from southeast France. It's already approved, as the President said, for the treatment of malaria [Trump had not said this, but had instead said it was now approved for COVID-19] as well as an arthritis condition.

Chloroquine and remdesivir are among the drugs the World Health Organization said would be tried in a five-part worldwide study announced Wednesday. "When you go with a brand new drug, you don't know what's going to happen".

Chloroquine is widely available now and could be used off-label, but officials want a formal study to get good information on safety and effectiveness. The benefit of this compassionate use model is that doctors who take advantage of that are then required to share back all patient info regarding administration and response to the drug, which helps inform ongoing trials and regulatory efforts. They recovered, but it's impossible to know whether they would have anyway without the drug.

"We now work with four different distributors and as of today are unable to order any chloroquine or hydroxychloroquine", which are on back order, David Light, chief executive of online pharmacy Valisure, said in an emailed statement. "That's the kind of can-do spirit that we are hearing and seeing", Kudlow said.

In addition, comparing untreated patients, those receiving hydroxychloroquine and those given hydroxychloroquine plus the antibiotic azithromycin, the results showed there was "a spectacular reduction in the number of positive cases" with the combination therapy, said Prof.

Developed by Gilead Sciences, remdesivir is described as an "investigational broad-spectrum antiviral treatment".

"There is evidence that chloroquine is effective when they looked at SARS in vitro with primate cells", said Dr. Len Horovitz, a pulmonologist and internist at Lenox Hill Hospital in New York City, told ABC News. In animal tests, it was "quite effective at preventing infection" and reducing severity of illness and damage to the lungs when given early enough in the course of illness, he said. When that happens, people become infected. While Health is trying to keep our stories as up-to-date as possible, we also encourage readers to stay informed on news and recommendations for their own communities by using the CDC, WHO, and their local public health department as resources. It targets interleukin-6, which plays a role in inflammation.

"During the briefing, the President said, 'We're going to be able to make that drug available nearly immediately, and that's where the FDA (Food and Drug Administration) has been so great", Trump told reporters. "One of the reasons to use this drug, even if there were better ones out there, is that chloroquine may be realistic to use".

Related Articles